TG Therapeutics, Inc. (TGTX) stock
TGTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/303% above fair value
$62.71−0.05 (-0.08%)
Close on Nov 17, 2026Market cap $9.60BP/E 22.9Yield –
TG Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
TG Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was 55.2%. For fiscal 2025 it was 72.6%, against 7.1% the year before. The highest annual figure on record is 72.6% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 72.6% | +65.5 |
| FY2024 | Dec 31, 2024 | 7.1% | +1.7 |
| FY2023 | Dec 31, 2023 | 5.4% | +8041.8 |
| FY2022 | Dec 31, 2022 | -8036.3% | −2832.3 |
| FY2021 | Dec 31, 2021 | -5204.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 3.2% | −16.7 |
| Q1 FY2026 | Mar 31, 2026 | 9.7% | +5.5 |
| Q4 FY2025 | Dec 31, 2025 | 12.0% | −9.6 |
| Q3 FY2025 | Sep 30, 2025 | 241.7% | +237.1 |
| Q2 FY2025 | Jun 30, 2025 | 20.0% | +10.6 |
| Q1 FY2025 | Mar 31, 2025 | 4.2% | +21.1 |
| Q4 FY2024 | Dec 31, 2024 | 21.6% | +54.4 |
| Q3 FY2024 | Sep 30, 2024 | 4.6% | −64.1 |
| Q2 FY2024 | Jun 30, 2024 | 9.4% | +305.6 |
| Q1 FY2024 | Mar 31, 2024 | -16.9% | +485.9 |
| Q4 FY2023 | Dec 31, 2023 | -32.8% | +98056.0 |
| Q3 FY2023 | Sep 30, 2023 | 68.7% | +38173.0 |
| Q2 FY2023 | Jun 30, 2023 | -296.2% | +6523.7 |
| Q1 FY2023 | Mar 31, 2023 | -502.8% | +2920.5 |
| Q4 FY2022 | Dec 31, 2022 | -98088.8% | +6045.5 |
| Q3 FY2022 | Sep 30, 2022 | -38104.3% | +124869.4 |
| Q2 FY2022 | Jun 30, 2022 | -6819.9% | +88477.5 |
| Q1 FY2022 | Mar 31, 2022 | -3423.3% | +89092.5 |
| Q4 FY2019 | Dec 31, 2019 | -104134.2% | +37602.6 |
| Q3 FY2019 | Sep 30, 2019 | -162973.7% | −73628.9 |
| Q2 FY2019 | Jun 30, 2019 | -95297.4% | +20865.8 |
| Q1 FY2019 | Mar 31, 2019 | -92515.8% | +16771.1 |
| Q4 FY2018 | Dec 31, 2018 | -141736.8% | −60526.3 |
| Q3 FY2018 | Sep 30, 2018 | -89344.7% | −6355.3 |
| Q2 FY2018 | Jun 30, 2018 | -116163.2% | −41550.0 |
| Q1 FY2018 | Mar 31, 2018 | -109286.8% | – |
| Q4 FY2017 | Dec 31, 2017 | -81210.5% | – |
| Q3 FY2017 | Sep 30, 2017 | -82989.5% | – |
| Q2 FY2017 | Jun 30, 2017 | -74613.2% | – |
See a number that looks wrong?